We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toSession-3-Track-2A-Personalized-Medicine-Gene-Therapy

Medical Affairs and Scientific Communications Forum

Medical Communication, MSL, and Medical Writing.

Session 11 Track 2B: Personalized Medicine: Gene Therapy

    Session Chair(s)
      Eileen  Girten, MS

      Eileen Girten, MS

      • Principal Medical Writer
      • PRA Health Sciences, United States
    You will leave this session with a basic understanding of what gene therapy is, how gene therapy works, and the challenges associated with education and awareness in the gene therapy space.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Differentiate between basic types of gene therapy
    • Explain how gene therapy works using simple terms
    • Describe the key challenges associated with educating audiences about gene therapy
    • Identify key insights regarding the straightforward communication of complex science
      Kendra  Bolt, PhD

      AAV Gene Therapies for Rare Diseases

      Kendra Bolt, PhD

      • Senior Manager of Scientific Communications
      • Audentes Therapeutics, United States